Kenya BioVax Institute Limited (KBI)

The Kenya BioVax Institute (BioVax) is a State agency mandated to manufacture, package and commercialize specialized health products and technologies, including vaccines, therapeutics and other biomedical products. BioVax will lead the country in realizing the dream of locally manufacturing human vaccines. Immunization is a key tool in the control and elimination of life-threatening infectious diseases. Globally, it is known to save 2 to 3 million lives annually. Currently, the United Nations Childrens Emergency Fund Supply Division (UNICEF SD) procurement services, through the support of the Global Alliance for Vaccines and Immunization (GAVI), is the predominant procurement mechanism of human vaccines for 45 of the 54 countries in Africa, including Kenya. However, for Kenya, the situation changed when the country graduated to become a lower-middle income nation in 2014, which in effect required the gradual weaning of the country from the GAVI support program on vaccine procureme...